Compugen Stock Investor Sentiment
| CGEN Stock | USD 1.74 0.05 2.79% |
About 53% of Compugen's investor base is interested to short. The analysis of overall sentiment of trading Compugen stock suggests that many investors are impartial at this time. Compugen's investing sentiment overview a quick insight into current market opportunities from investing in Compugen. Many technical investors use Compugen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Compugen Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Compugen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors may consider stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to consider selling stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Compugen's Stock prices. Below is the latest headlines and news related to Compugen Stock. Current markets are strongly bullish. About 70% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.
Compugen Largest EPS Surprises
Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2011-11-08 | 2011-09-30 | -0.09 | -0.1 | -0.01 | 11 | ||
2011-05-11 | 2011-03-31 | -0.07 | -0.06 | 0.01 | 14 | ||
2010-02-09 | 2009-12-31 | -0.08 | -0.07 | 0.01 | 12 | ||
2009-10-27 | 2009-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2025-08-06 | 2025-06-30 | -0.06 | -0.08 | -0.02 | 33 | ||
2023-11-07 | 2023-09-30 | -0.09 | -0.11 | -0.02 | 22 |
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.
Compugen Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to 90 Million | 12/17/2025 |
2 | TIGIT Inhibitors Drugs Clinical Trials Global Market Opportunity Report 2026-2030 Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnol... | 01/06/2026 |
3 | Compugen Partners with AXL to Support Canadas AI Commercialization | 01/26/2026 |
4 | AstraZeneca results FY and Q4 2025 | 02/10/2026 |
5 | Compugen to Participate in Upcoming Investor Conferences | 02/19/2026 |
Check out To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.